2031년까지의 남미 및 중미 약동학 서비스 시장 전망 - 지역 분석 - 약물 유형(소분자, 대분자 및 백신), 서비스 유형(임상 전 ADME 및 인체 연구, PK/PD 분석 및 보고, 투여 시뮬레이션, 위험 분석 및 기타), 치료적 응용(종양학, 감염성 질환, 신경계 질환, 자가면역 질환, 부인과 질환, 심혈관 질환, 호흡기 질환 및 기타), 최종 사용자(제약 및 생명공학 회사, 계약 연구 기관 및 기타)
CRO에 대한 약동학 서비스 아웃소싱이 남미 및 중미 약동학 서비스 시장을 활성화합니다
약동학 서비스를 계약 연구 기관(CRO)에 아웃소싱하면 약물 제조업체와 스폰서에게 여러 가지 이점이 있습니다. 이러한 서비스를 선택하면 비용 효율적으로 운영할 수 있습니다. 게다가 유연한 작업에 집중하고 핵심 운영에 확장성을 도입하면서 빠른 처리 시간을 달성할 수 있습니다. 아웃소싱을 통해 제약 회사는 용량 구축, 비용 절감 및 데이터 관리를 위한 조치를 구현하는 동시에 제품 상용화에 집중할 수 있습니다. 약물 발견 프로세스는 복잡하며 오류나 잘못된 결과가 있으면 상당한 비용이 발생하고 프로세스가 지연될 수 있습니다. CRO는 약동학 및 기타 분야에 대한 전문 지식을 보유한 숙련된 과학자와 연구자를 고용합니다. 따라서 제약 회사가 전문 지식에 액세스할 수 있도록 하여 숙련된 인력을 고용하거나 인력을 구축하기 위한 추가 교육을 제공하는 데 투자할 필요가 없습니다. 따라서 유망한 약물 후보가 있지만 자원이 부족한 소규모 회사와 운영을 다각화하는 데 관여하는 대기업은 잘 조직된 CRO가 제공하는 임상 연구 서비스를 선택하고 있으며, 이는 약동학 서비스 시장을 강화합니다.
남미 및 중미 약동학 서비스 시장 개요
브라질은 임상 시험의 주요 목적지입니다. Clinical Trials Arena에 따르면 2021년 브라질은 글로벌 임상 시험 활동의 1.7%를 차지했습니다. 2022년 7월, Boston CRO는 리우데자네이루에 본사를 둔 Instituto Brasil de Pesquisa Clinica(IBPClin)를 인수하여 라틴 아메리카에서 분산형 임상 시험 제공 모델을 구현하기 위한 첫 걸음을 내디뎠습니다. 12개 브라질 주에 걸쳐 7,000명 이상의 참여자를 등록하여 160개 이상의 산업 후원 연구를 수행했다고 주장합니다. IBPClin은 남미에서 가장 큰 연구 센터입니다. 2020년 3월, Fiocruz 재단은 세계보건기구(WHO)의 지원을 받는 임상 시험에 투자하기로 약속하면서 새로운 병원 센터를 건립했습니다. 이 새로운 병원은 브라질에서 Fiocruz가 이끄는 Solidarity 임상 시험을 주최할 예정이며, 이 이니셔티브는 보건부 과학기술부의 지원을 받아 브라질 12개 주의 18개 병원에서 시행되고 INI/Fiocruz가 조정합니다. 따라서 임상 연구 개발을 위해 취해진 이러한 이니셔티브는 브라질의 약동학 서비스 시장 성장을 촉진합니다.
남중미 약동학 서비스 시장 수익 및 2031년 예측(백만 달러)
남중미 약동학 서비스 시장 세분화
남중미 약동학 서비스 시장은 약물 유형, 서비스 유형, 치료적 적용, 최종 사용자 및 국가로 분류됩니다.
약물 유형을 기준으로 남중미 약동학 서비스 시장은 소분자, 대분자 및 백신으로 세분화됩니다. 소분자 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.
서비스 유형 측면에서 남중미 약동학 서비스 시장은 임상 전 ADME 및 인체 연구, PK/PD 분석 및 보고, 투여 시뮬레이션, 위험 분석 및 기타로 분류됩니다. 영어: 전임상 ADME 및 인체 연구 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.
치료적 적용 기준으로 남중미 약동학 서비스 시장은 종양학, 감염성 질환, 신경계 질환, 자가면역 질환, 부인과 질환, 심혈관 질환, 호흡기 질환 등으로 세분화됩니다. 종양학 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.
최종 사용자 기준으로 남중미 약동학 서비스 시장은 제약 및 생명 공학 회사, 계약 연구 기관 등으로 세분화됩니다. 계약 연구 기관 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.
국가 기준으로 남중미 약동학 서비스 시장은 브라질, 아르헨티나, 남중미의 나머지 지역으로 세분화됩니다. 브라질은 2023년에 남중미 약동학 서비스 시장 점유율을 지배했습니다.
Charles River Laboratories International Inc;Eurofins Scientific SE;Certara Inc.; Parexel International Corp; Thermo Fisher Scientific Inc.; Allucent; PACIFIC BIOLABS; SGS SA는 중남미 약동학 서비스 시장에서 활동하는 대표적인 기업입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Pharmacokinetics Services Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Chronic and Infectious Diseases
4.1.2 Expanding Range of Application of Pharmacokinetic Studies
4.1.3 Outsourcing of Pharmacokinetics Services to CROs
4.2 Market Restraints
4.2.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries
4.3 Market Opportunities
4.3.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics
4.4 Future Trend
4.4.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services
4.5 Impact of Drivers and Restraints:
5. Pharmacokinetics Services Market - South & Central America Analysis
5.1 South & Central America Pharmacokinetics Services Market Overview
5.2 South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
6. South & Central America Pharmacokinetics Services Market Analysis - by Drug Type
6.1 Overview
6.2 Small Molecule
6.2.1 Overview
6.2.2 Small Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Large Molecule
6.3.1 Overview
6.3.2 Large Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7. South & Central America Pharmacokinetics Services Market Analysis - by Service Type
7.1 Overview
7.2 Pre-Clinical ADME and Human Studies
7.2.1 Overview
7.2.2 Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.3 PK/PD Analysis and Reporting
7.3.1 Overview
7.3.2 PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Dosing Simulations
7.4.1 Overview
7.4.2 Dosing Simulations: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Risk Analysis
7.5.1 Overview
7.5.2 Risk Analysis: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8. South & Central America Pharmacokinetics Services Market Analysis - by Therapeutic Application
8.1 Oncology
8.1.1 Overview
8.1.2 Oncology: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Infectious Diseases
8.2.1 Overview
8.2.2 Infectious Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Neurological Disorders
8.3.1 Overview
8.3.2 Neurological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Autoimmune Diseases
8.4.1 Overview
8.4.2 Autoimmune Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Gynecological Disorders
8.5.1 Overview
8.5.2 Gynecological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Cardiovascular Diseases
8.6.1 Overview
8.6.2 Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Respiratory Disorders
8.7.1 Overview
8.7.2 Respiratory Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9. South & Central America Pharmacokinetics Services Market Analysis - by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Contract Research Organization
9.2.1 Overview
9.2.2 Contract Research Organization: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10. South & Central America Pharmacokinetics Services Market - Country Analysis
10.1 South & Central America
10.1.1 South & Central America Pharmacokinetics Services Market Breakdown by Countries, 2023 and 2031 (%)
10.1.1.1 Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.3 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.1.4 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.1.5 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.1.6 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by End User
10.1.1.2 Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.2.4 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.2.5 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.2.6 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by End User
10.1.1.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.3.4 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.3.5 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.3.6 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by End User
11. Company Profile
11.1 Charles River Laboratories International Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Eurofins Scientific SE
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Certara Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Parexel International Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Thermo Fisher Scientific Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Allucent
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 PACIFIC BIOLABS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 SGS SA
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms for Pharmacokinetic Services Market
?
List of Tables
Table 1. South & Central America Pharmacokinetics Services Market Segmentation
Table 2. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type
Table 3. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type
Table 4. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application
Table 5. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type
Table 7. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type
Table 8. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application
Table 9. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type
Table 11. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type
Table 12. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application
Table 13. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 14. Glossary of Terms
?
List of Figures
Figure 1. South & Central America Pharmacokinetics Services Market Segmentation, by Country
Figure 2. South & Central America Pharmacokinetics Services Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
Figure 5. South & Central America Pharmacokinetics Services Market Share (%) - by Drug Type (2023 and 2031)
Figure 6. Small Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Large Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Vaccines: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. South & Central America Pharmacokinetics Services Market Share (%) - by Service Type (2023 and 2031)
Figure 10. Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Dosing Simulations: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Risk Analysis: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. South & Central America Pharmacokinetics Services Market Share (%) - by Therapeutic Application (2023 and 2031)
Figure 16. Oncology: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Infectious Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Neurological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Autoimmune Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Gynecological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Respiratory Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. South & Central America Pharmacokinetics Services Market Share (%) - by End User (2023 and 2031)
Figure 25. Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Contract Research Organization: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. South & Central America Pharmacokinetics Services Market by Key Countries - Revenue (2023) (US$ Million)
Figure 29. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- Charles River Laboratories International Inc
- Eurofins Scientific SE
- Certara Inc.
- Parexel International Corp
- Thermo Fisher Scientific Inc.
- Allucent
- PACIFIC BIOLABS
- SGS SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America pharmacokinetics services market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America pharmacokinetics services market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America pharmacokinetics services market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.